The measure addresses adherence to three types of chronic medications: statins, levothyroxine, and angiotensin converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs). The measure is divided into three submeasures:
Measure A: The percentage of eligible individuals who had at least two prescriptions for statins and who have a Proportion of Days Covered (PDC) of at least 0.8 during the measurement period (12 consecutive months).
Measure B: The percentage of eligible individuals who had at least two prescriptions for levothyroxine and who have a PDC of at least 0.8 during the measurement period (12 consecutive months).
Measure C: The percentage of eligible individuals who had at least two prescriptions for ACEIs/ARBs and who have a PDC of at least 0.8 during the measurement period (12 consecutive months).
-
-
1.5 Measure Type1.7 Electronic Clinical Quality Measure (eCQM)1.8 Level Of Analysis1.9 Care Setting1.20 Testing Data Sources
-
1.14 Numerator
Numerator A: Individuals with at least two prescriptions for statins having a PDC of at least 0.8.
Numerator B: Individuals with at least two prescriptions for levothyroxine having a PDC of at least 0.8.
Numerator C: Individuals with at least two prescriptions for ACEIs/ARBs having a PDC of at least 0.8.
-
1.15 Denominator
Denominator A: Individuals with at least two prescriptions for statins.
Denominator B: Individuals with at least two prescriptions for levothyroxine.
Denominator C: Individuals with at least two prescriptions for ACEIs/ARBs.
-
Exclusions
Not Applicable
-
Most Recent Endorsement ActivityMeasure Retired and Endorsement Removed Patient Safety Project 2013-2014Initial EndorsementLast UpdatedRemoval Date
-
Steward Organization Email
-
-
-
Risk Adjustment
-
-
-
6.1.2 Current or Planned Use(s)6.1.3 Current Use(s)
-